(2S,4R)-1-[(2S)-2-[4-[4-[[4-(4'-chloro-5'-oxospiro[cyclohexane-1,7'-indolo[1,2-a]quinazoline]-10'-yl)piperidin-1-yl]methyl]cyclohexyl]triazol-1-yl]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-5-yl]phenyl]ethyl]pyrrolidine-2-carboxamide

C63H79ClN10O5S — CID 171104807

IUPAC(2S,4R)-1-[(2S)-2-[4-[4-[[4-(4'-chloro-5'-oxospiro[cyclohexane-1,7'-indolo[1,2-a]quinazoline]-10'-yl)piperidin-1-yl]methyl]cyclohexyl]triazol-1-yl]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-5-yl]phenyl]ethyl]pyrrolidine-2-carboxamide
SMILESC[C@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](n1cc(C2CCC(CN3CCC(c4ccc5c(c4)-n4c(nc(=O)c6c(Cl)cccc64)C54CCCCC4)CC3)CC2)nn1)C(C)(C)C)c1ccc(-c2scnc2CCCN2CCOCC2)cc1
InChIInChI=1S/C63H79ClN10O5S/c1-40(42-17-19-45(20-18-42)56-50(65-39-80-56)11-9-27-70-30-32-79-33-31-70)66-58(76)54-35-47(75)37-72(54)60(78)57(62(2,3)4)73-38-51(68-69-73)44-15-13-41(14-16-44)36-71-28-23-43(24-29-71)46-21-22-48-53(34-46)74-52-12-8-10-49(64)55(52)59(77)67-61(74)63(48)25-6-5-7-26-63/h8,10,12,17-22,34,38-41,43-44,47,54,57,75H,5-7,9,11,13-16,23-33,35-37H2,1-4H3,(H,66,76)/t40-,41?,44?,47+,54-,57+/m0/s1
InChIKeyRCNWNDBSEKEMNT-TVSQDCDFSA-N
MW1123.91 g/mol
LogP10.16
Rot. Bonds14

About (2S,4R)-1-[(2S)-2-[4-[4-[[4-(4'-chloro-5'-oxospiro[cyclohexane-1,7'-indolo[1,2-a]quinazoline]-10'-yl)piperidin-1-yl]methyl]cyclohexyl]triazol-1-yl]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-5-yl]phenyl]ethyl]pyrrolidine-2-carboxamide

(2S,4R)-1-[(2S)-2-[4-[4-[[4-(4'-chloro-5'-oxospiro[cyclohexane-1,7'-indolo[1,2-a]quinazoline]-10'-yl)piperidin-1-yl]methyl]cyclohexyl]triazol-1-yl]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-5-yl]phenyl]ethyl]pyrrolidine-2-carboxamide (PubChem CID 171104807) has the molecular formula C63H79ClN10O5S and a molecular weight of 1123.91 g/mol. Its IUPAC name is (2S,4R)-1-[(2S)-2-[4-[4-[[4-(4'-chloro-5'-oxospiro[cyclohexane-1,7'-indolo[1,2-a]quinazoline]-10'-yl)piperidin-1-yl]methyl]cyclohexyl]triazol-1-yl]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-5-yl]phenyl]ethyl]pyrrolidine-2-carboxamide.

Molecular Properties

Compound Name(2S,4R)-1-[(2S)-2-[4-[4-[[4-(4'-chloro-5'-oxospiro[cyclohexane-1,7'-indolo[1,2-a]quinazoline]-10'-yl)piperidin-1-yl]methyl]cyclohexyl]triazol-1-yl]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-5-yl]phenyl]ethyl]pyrrolidine-2-carboxamide
PubChem CID171104807
Molecular FormulaC63H79ClN10O5S
Molecular Weight1123.91 g/mol
Exact Mass1122.56
IUPAC Name(2S,4R)-1-[(2S)-2-[4-[4-[[4-(4'-chloro-5'-oxospiro[cyclohexane-1,7'-indolo[1,2-a]quinazoline]-10'-yl)piperidin-1-yl]methyl]cyclohexyl]triazol-1-yl]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-5-yl]phenyl]ethyl]pyrrolidine-2-carboxamide
SMILESC[C@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](n1cc(C2CCC(CN3CCC(c4ccc5c(c4)-n4c(nc(=O)c6c(Cl)cccc64)C54CCCCC4)CC3)CC2)nn1)C(C)(C)C)c1ccc(-c2scnc2CCCN2CCOCC2)cc1
InChIInChI=1S/C63H79ClN10O5S/c1-40(42-17-19-45(20-18-42)56-50(65-39-80-56)11-9-27-70-30-32-79-33-31-70)66-58(76)54-35-47(75)37-72(54)60(78)57(62(2,3)4)73-38-51(68-69-73)44-15-13-41(14-16-44)36-71-28-23-43(24-29-71)46-21-22-48-53(34-46)74-52-12-8-10-49(64)55(52)59(77)67-61(74)63(48)25-6-5-7-26-63/h8,10,12,17-22,34,38-41,43-44,47,54,57,75H,5-7,9,11,13-16,23-33,35-37H2,1-4H3,(H,66,76)/t40-,41?,44?,47+,54-,57+/m0/s1
InChIKeyRCNWNDBSEKEMNT-TVSQDCDFSA-N
XLogP10.16
TPSA163.84 Ų
H-Bond Donors2
H-Bond Acceptors14
Rotatable Bonds14
Heavy Atoms80
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001123.91
LogP ≤ 510.16
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1014

Analyze (2S,4R)-1-[(2S)-2-[4-[4-[[4-(4'-chloro-5'-oxospiro[cyclohexane-1,7'-indolo[1,2-a]quinazoline]-10'-yl)piperidin-1-yl]methyl]cyclohexyl]triazol-1-yl]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-5-yl]phenyl]ethyl]pyrrolidine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S,4R)-1-[(2S)-2-[4-[4-[[4-(4'-chloro-5'-oxospiro[cyclohexane-1,7'-indolo[1,2-a]quinazoline]-10'-yl)piperidin-1-yl]methyl]cyclohexyl]triazol-1-yl]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-5-yl]phenyl]ethyl]pyrrolidine-2-carboxamide?
The IUPAC name of (2S,4R)-1-[(2S)-2-[4-[4-[[4-(4'-chloro-5'-oxospiro[cyclohexane-1,7'-indolo[1,2-a]quinazoline]-10'-yl)piperidin-1-yl]methyl]cyclohexyl]triazol-1-yl]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-5-yl]phenyl]ethyl]pyrrolidine-2-carboxamide (CID 171104807) is (2S,4R)-1-[(2S)-2-[4-[4-[[4-(4'-chloro-5'-oxospiro[cyclohexane-1,7'-indolo[1,2-a]quinazoline]-10'-yl)piperidin-1-yl]methyl]cyclohexyl]triazol-1-yl]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-5-yl]phenyl]ethyl]pyrrolidine-2-carboxamide.
What is the SMILES notation for (2S,4R)-1-[(2S)-2-[4-[4-[[4-(4'-chloro-5'-oxospiro[cyclohexane-1,7'-indolo[1,2-a]quinazoline]-10'-yl)piperidin-1-yl]methyl]cyclohexyl]triazol-1-yl]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-5-yl]phenyl]ethyl]pyrrolidine-2-carboxamide?
The canonical SMILES for (2S,4R)-1-[(2S)-2-[4-[4-[[4-(4'-chloro-5'-oxospiro[cyclohexane-1,7'-indolo[1,2-a]quinazoline]-10'-yl)piperidin-1-yl]methyl]cyclohexyl]triazol-1-yl]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-5-yl]phenyl]ethyl]pyrrolidine-2-carboxamide is C[C@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](n1cc(C2CCC(CN3CCC(c4ccc5c(c4)-n4c(nc(=O)c6c(Cl)cccc64)C54CCCCC4)CC3)CC2)nn1)C(C)(C)C)c1ccc(-c2scnc2CCCN2CCOCC2)cc1.
What is the InChIKey of (2S,4R)-1-[(2S)-2-[4-[4-[[4-(4'-chloro-5'-oxospiro[cyclohexane-1,7'-indolo[1,2-a]quinazoline]-10'-yl)piperidin-1-yl]methyl]cyclohexyl]triazol-1-yl]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-5-yl]phenyl]ethyl]pyrrolidine-2-carboxamide?
The InChIKey is RCNWNDBSEKEMNT-TVSQDCDFSA-N. The full InChI is InChI=1S/C63H79ClN10O5S/c1-40(42-17-19-45(20-18-42)56-50(65-39-80-56)11-9-27-70-30-32-79-33-31-70)66-58(76)54-35-47(75)37-72(54)60(78)57(62(2,3)4)73-38-51(68-69-73)44-15-13-41(14-16-44)36-71-28-23-43(24-29-71)46-21-22-48-53(34-46)74-52-12-8-10-49(64)55(52)59(77)67-61(74)63(48)25-6-5-7-26-63/h8,10,12,17-22,34,38-41,43-44,47,54,57,75H,5-7,9,11,13-16,23-33,35-37H2,1-4H3,(H,66,76)/t40-,41?,44?,47+,54-,57+/m0/s1.
What are the key properties of (2S,4R)-1-[(2S)-2-[4-[4-[[4-(4'-chloro-5'-oxospiro[cyclohexane-1,7'-indolo[1,2-a]quinazoline]-10'-yl)piperidin-1-yl]methyl]cyclohexyl]triazol-1-yl]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-5-yl]phenyl]ethyl]pyrrolidine-2-carboxamide?
(2S,4R)-1-[(2S)-2-[4-[4-[[4-(4'-chloro-5'-oxospiro[cyclohexane-1,7'-indolo[1,2-a]quinazoline]-10'-yl)piperidin-1-yl]methyl]cyclohexyl]triazol-1-yl]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-5-yl]phenyl]ethyl]pyrrolidine-2-carboxamide has a molecular weight of 1123.91 g/mol, XLogP of 10.16, 14 rotatable bonds, 2 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for (2S,4R)-1-[(2S)-2-[4-[4-[[4-(4'-chloro-5'-oxospiro[cyclohexane-1,7'-indolo[1,2-a]quinazoline]-10'-yl)piperidin-1-yl]methyl]cyclohexyl]triazol-1-yl]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-5-yl]phenyl]ethyl]pyrrolidine-2-carboxamide is sourced from PubChem (CID 171104807), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).